Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report) crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.39 and traded as low as $0.25. Cell MedX shares last traded at $0.25, with a volume of 167 shares trading hands.
Cell MedX Stock Performance
The business’s fifty day moving average is $0.39 and its 200 day moving average is $0.28.
Cell MedX Company Profile
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Featured Articles
- Five stocks we like better than Cell MedX
- Do ETFs Pay Dividends? What You Need to Know
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- Stock Analyst Ratings and Canadian Analyst Ratings
- MarketBeat Week in Review – 03/24 – 03/28
- EV Stocks and How to Profit from Them
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
